000 | 01993 a2200601 4500 | ||
---|---|---|---|
005 | 20250516024705.0 | ||
264 | 0 | _c20110705 | |
008 | 201107s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2011.01.129 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatson, Nigel S | |
245 | 0 | 0 |
_aThe discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cMar 2011 |
||
300 |
_a1588-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzazepines _xadministration & dosage |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aFactor Xa Inhibitors |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aTetrahydroisoquinolines _xadministration & dosage |
700 | 1 | _aAdams, Carl | |
700 | 1 | _aBelton, David | |
700 | 1 | _aBrown, David | |
700 | 1 | _aBurns-Kurtis, Cynthia L | |
700 | 1 | _aChaudry, Laiq | |
700 | 1 | _aChan, Chuen | |
700 | 1 | _aConvery, Máire A | |
700 | 1 | _aDavies, David E | |
700 | 1 | _aExall, Anne M | |
700 | 1 | _aHarling, John D | |
700 | 1 | _aIrvine, Stephanie | |
700 | 1 | _aIrving, Wendy R | |
700 | 1 | _aKleanthous, Savvas | |
700 | 1 | _aMcLay, Iain M | |
700 | 1 | _aPateman, Anthony J | |
700 | 1 | _aPatikis, Angela N | |
700 | 1 | _aRoethke, Theresa J | |
700 | 1 | _aSenger, Stefan | |
700 | 1 | _aStelman, Gary J | |
700 | 1 | _aToomey, John R | |
700 | 1 | _aWest, Robert I | |
700 | 1 | _aWhittaker, Caroline | |
700 | 1 | _aZhou, Ping | |
700 | 1 | _aYoung, Robert J | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 21 _gno. 6 _gp. 1588-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2011.01.129 _zAvailable from publisher's website |
999 |
_c20625132 _d20625132 |